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doi:10.1016/j.jfma.2012.04.005A 45-year-old man, a case of acquired immunodeficiency syndrome, received a highly active
antiretroviral therapy at the outpatient service for 4 years without regular follow-up. He expe-
rienced progressively blurred vision for 6 months and a cutaneous zoster on his back 3 months
ago. He was diagnosed with progressive outer retinal necrosis by polymerase chain reaction-
restriction fragment length polymorphism using an aqueous humor sample, which revealed
an existence of varicella zoster virus. He was given a combination of systemic, intravitreal
antiviral and a highly active antiretroviral therapy. Occlusive vasculitis, an unusual finding
for progressive outer retinal necrosis, developed in both eyes 1 week after the secondary in-
travitreal injection. Unfortunately, his vision deteriorated to no light perception in both eyes
within 2 weeks. Progressive outer retinal necrosis is characterized clinically as showing
minimal or no inflammation in the aqueous and vitreous humors, absence of retinal vasculitis,
and patches of yellowish spots located deep in the retina. Physicians should pay attention to
this rare case of progressive outer retinal necrosis associated occlusive vasculitis with very
poor prognosis in spite of aggressive treatment.
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Progressive outer retinal necrosis is a viral retinitis most
commonly caused by varicella zoster virus (VZV) and
occasionally by varicella simplex virus (HSV). Both viruses
occur in immunocompromised patients, particularly those
with acquired immunodeficiency syndrome (AIDS). The
CD4 þ T-cell counts of these patients are low (20e50 cells/
mm3) before the use of highly active antiretroviral therapy
(HAART).1e3 Patients usually have painless and rapid visual
loss and may have a cutaneous zoster history. In comparison
with acute retinal necrosis (ARN), progressive outer retinal
necrosis is characterized by minimal inflammation in the
aqueous and vitreous humors and rarely results in occlusive
vasculitis. Total retinal detachment (RD) is usually a major
consequence resulting from diffuse retinal necrosis. This
study reports the fulminant course of progressive outer
retinal necrosis in a patient with AIDS, occlusive vasculitis,
central retinal vein occlusion, vitreous hemorrhage (VH),
and RD despite aggressive and combined treatment that
involved both intravitreal antiviral therapy and HAART.Case report
A 45-year-old man, a case of acquired immunodeficiency
syndrome, presented with progressively blurred vision in
both eyes. Previously, he had only mildly blurred vision in
the left eye about 6 months ago and was also inflicted with
cutaneous zoster 3 months ago. For 4 years he had also
received HAART at our outpatient service center for
infectious diseases without regular follow-up. On the day of
admission, his vision was limited to hand movement in the
right eye and light perception in the left eye. Funduscopy
showed multifocal, patchy choroidal, and deep retinal
opacification with dots and blots of retinal hemorrhage in
both eyes (Fig. 1). Anterior chamber and vitreous cavity
showed no significant signs of inflammation. Both serum
Toxoplasma gondiiespecific immunoglobulin (Ig) G and IgM
and cytomegalovirus (CMV) IgM were negative. The aqueous
humor examined by polymerase chain reaction restriction-
fragment length polymorphism (PCR-RFLP) detected only
VZV. The HSV and CMV DNA were not identified in aqueous
humor. Under the impression of VZV-related chorioretinitis
of both eyes, he was treated with systemic ganciclovirFigure 1 Funduscopy showed multifocal, patchy choroidal, an
hemorrhage in both eyes.250 mg twice-daily plus sulfamethoxazole 400 mg and two
trimethoprim 80 mg tablets twice daily. Bilateral intra-
vitreal injections of ganciclovir (2 mg/0.05 ml) were also
performed.
He was administered efavirenz and intravenous ganci-
clovir, followed by continuation of HAART (lopinavir, rito-
navir, and efavirenz). On the seventh hospital day, the deep
white retinal lesions coalesced and expanded to the
peripheral retina with vision worsened to hand movement
in the right eye and no light perception in the left eye.
Optical coherence tomography (OCT) showed extensive
outer retinal necrosis (Fig. 2).
Repeated bilateral intravitreal injections of ganciclovir
(2 mg/0.05 ml) were given to the patient after one week,
but obliterative vasculitis, an unusual finding for progres-
sive outer retinal necrosis, developed and resulted in
central retinal vein occlusion in both eyes 1 week after the
secondary intravitreal injection (Fig. 3). The patient also
received a dose of acetylsalicylic acid and one tablet daily,
and OCT showed almost total loss of identifiable retina
layers with retinal necrosis in both eyes (Fig. 4).
To prevent bone marrow suppression in the patient, the
intravenous injection of ganciclovir was switched to val-
ganciclovir for 1 day and then to famciclovir. The HAART
regimen was also changed to lopinavir and ritonavir two
tablets twice daily plus abacavir and lamivudine one tablet
once daily due to suspicion of drug resistance.
Panretinal photocoagulation was performed but exten-
sive full-thickness necrosis with VH continued to develop
(Fig. 5). His vision deteriorated to no light perception in
both eyes within 2 weeks.
Discussion
Necrotizing herpetic retinopathy is a continuous spectrum
of diseases caused by herpes viruses, such as CMV, HSV, and
VZV. The clinical presentation depends on the immune
state of the patients, ranging from ARN to progressive outer
retinal necrosis in patients with normal immunity or
severely immunocompromised patients.4
Progressive outer retinal necrosis may involve any part
of the retina at presentation (including macula) with little
or no inflammation in anterior chamber or vitreous. Multi-
focal opacification of the deep retinal layers is usually seen
at onset. Scleritis and occlusive vasculopathy are rarelyd deep retinal opacification with dots and blots of retinal
Figure 2 Optical coherence tomography showed extensive outer retinal necrosis.
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usually progresses rapidly and eventually leads to rhegma-
togenous RD and blindness in both eyes within days or
weeks. The prognosis for this type of patients is generally
poor, with approximately one-half of them having a final
visual acuity of no light perception, despite aggressive
therapy with intravenous antiviral drugs. Prophylactic
photocoagulation preventing RD is not useful in most
patients.1,2
In comparison with progressive outer retinal necrosis,
CMV retinitis, a common (15%e40%) opportunistic infection
in AIDS before HAART, is rarely multifocal, although several
CMV lesions may coexist in one eye. ARN, retinopathy
caused by the same herpesviruses (most commonly HSV),
affects immunocompetent and immunocompromised
persons. In the beginning, episcleritis or scleritis with per-
iorbital pain is noted. Granulomatous anterior uveitis
associated with a necrotizing vasoocclusive retinitis,
arteritis and vitreitis is the characteristic finding. Initially,
ARN tends to involve the peripheral retina only. Bilateral
presentation is less frequent but RD is also common.
Progressive outer retinal necrosis has been reported to
have poor response to intravenous acyclovir therapy.1,2
Moorthy and colleagues2 reported that intravenous
ganciclovir plus foscarnet therapy or ganciclovir alone have
significantly better visual outcome than intravenous
acyclovir or foscarnet alone.Ciulla and others5 suggested
that prolonged combination of antiviral therapy (ganciclo-
vir and acyclovir, foscarnet and ganciclovir, foscarnet, and
acyclovir) might successfully arrest the progression of
retinitis, maintain remission, and prevent involvement of
the fellow eye.Figure 3 Obliterative vasculitis developed and resulted in centra
intravitreal injection.Successful intravitreal ganciclovir was first reported in
1997. Currently, the recommended dose is 2 mg.6Combined
intravenous and intravitreal antiviral therapy is proven to
be efficacious in disease control.7 In recent studies, various
researchers suggest that intravenous acyclovir plus foscar-
net, ganciclovir plus foscarnet, intravitreal ganciclovir
combined with intravenous acyclovir or foscarnet, and
intravitreal ganciclovir combined with foscarnet as well as
prophylactic laser photocoagulation have important roles in
the management of progressive outer retinal necrosis.2,5e8
HAART may have benefit on progressive outer retinal
necrosis as it does on CMV retinitis by lowering the viral
load and maintaining high CD4 þ T-cell counts, although the
most effective regimen is unresolved.8 By contrast to CMV
retinitis, maintenance therapy is still necessary in
progressive outer retinal necrosis despite of immune
recovery after HAART.9 Combination of antiviral therapy
and HAART has also been reported to achieve successful
management. Serial aqueous PCR for VZV instead of sero-
logic antibody tests is recommended for monitoring
progressive outer retinal necrosis. OCT is another useful
tool for diagnosing and following-up progressive outer
retinal necrosis.
Our patient had poor drug compliance of HAART and the
CD4 count was less than 28 ml before admission. The
ophthalmic findings were characteristic for progressive
outer retinal necrosis, and included absence of intraocular
inflammation as well as rapid progression of confluent
yellow-white patches corresponding to full-thickness
retinal necrosis from the posterior pole to the periphery,
with the only difference of obliterative vasculitis leading to
retinal vein occlusion and vitreous hemorrhage. There wasl retinal vein occlusion in both eyes 1 week after the secondary
Figure 4 Optical coherence tomography showed a near total loss of identifiable retina layers with retinal necrosis in both eyes.
Figure 5 Extensive full-thickness necrosis with a developed vitreous hemorrhage.
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strategies were initiated as soon as possible. Panretinal
photocoagulation could hardly achieve its effect on full
necrotic retinal layers and vitreous hemorrhage was an
inevitable outcome.
A combination of systemic and intravitreal antiviral
therapy may result in disease remission and visual salvation
only in the early stage of progressive outer retinal necrosis.
Rapid recognition of progressive outer retinal necrosis can
be achieved by clinical pictures, aqueous PCR analysis and
characteristic OCT findings. Early initiation of aggressive
and combined therapy is very critical to successful disease
management.
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